The Effects of Treatment on Body Mass Index in Giant Cell Arteritis: A Post Hoc Analysis of the GiACTA Trial

INTRODUCTION: Giant cell arteritis (GCA) requires treatment with high-dose, long-term glucocorticoids (GCs), and tocilizumab is often used early in the treatment paradigm. Weight gain, which is associated with morbidity and mortality, is a major concern for patients, though the factors that contribu...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Naomi J., Fu, Xiaoqing, Zhang, Yuqing, Unizony, Sebastian H., Wallace, Zachary S., Choi, Hyon K., Stone, John H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964534/
https://www.ncbi.nlm.nih.gov/pubmed/34954809
http://dx.doi.org/10.1007/s40744-021-00411-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964534/
https://www.ncbi.nlm.nih.gov/pubmed/34954809
http://dx.doi.org/10.1007/s40744-021-00411-y

Ejemplares similares